| Year |
Citation |
Score |
| 2024 |
Graillon T, Salgues B, Horowitz T, Padovani L, Appay R, Tabouret E, Guedj E, Chinot O. Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis. Journal of Neuro-Oncology. PMID 38451361 DOI: 10.1007/s11060-024-04622-5 |
0.54 |
|
| 2023 |
Harlay V, Appay R, Bequet C, Petrirena G, Campello C, Barrié M, Autran D, Graillon T, Boissonneau S, Dufour H, Figarella-Branger D, Padovani L, Barlier A, Nanni I, Tabouret E, et al. Radio-chemotherapy feasibility for biopsy-only unresectable wild-type glioblastomas (BO-GBM). Neuro-Oncology Practice. 10: 536-543. PMID 38009116 DOI: 10.1093/nop/npad028 |
0.622 |
|
| 2020 |
Carrie C, Kieffer V, Figarella-Branger D, Masliah-Planchon J, Bolle S, Bernier V, Laprie A, Supiot S, Leseur J, Habrand JL, Alapetite C, Kerr C, Dufour C, Claude L, Chapet S, ... ... Padovani L, et al. Exclusive Hyper-fractionated Radiotherapy and reduced boost volume for standard-risk medulloblastoma: pooled analysis of the two French multicentric studies MSFOP98 and MSFOP 2007 and correlation with molecular subgroups. International Journal of Radiation Oncology, Biology, Physics. PMID 32768563 DOI: 10.1016/J.Ijrobp.2020.07.2324 |
0.678 |
|
| 2020 |
Le Bon M, Lejeune H, Helfre S, Bolle S, Padovani L, Mengue L, Corradini N, Hameury F, Claude L. Testicular transposition in children before scrotal external radiotherapy. Pediatric Blood & Cancer. e28526. PMID 32618059 DOI: 10.1002/Pbc.28526 |
0.307 |
|
| 2020 |
Baliga S, Gandola L, Timmermann B, Gail H, Padovani L, Janssens GO, Yock TI. Brain tumors: Medulloblastoma, ATRT, ependymoma. Pediatric Blood & Cancer. e28395. PMID 32386126 DOI: 10.1002/Pbc.28395 |
0.396 |
|
| 2019 |
Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L, Muracciole X, Supiot S, Huchet A, Leseur J, et al. Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Frontiers in Oncology. 9: 531. PMID 31293971 DOI: 10.3389/Fonc.2019.00531 |
0.329 |
|
| 2019 |
Autran D, Barrie M, Matta M, Monserrat C, Campello C, Petrirena G, Boucard C, Padovani L, Loundou A, Appay R, Graillon T, Dufour H, Figarella-Branger D, Chinot O, Tabouret E. Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients. Anticancer Research. 39: 1035-1041. PMID 30711992 DOI: 10.21873/Anticanres.13210 |
0.636 |
|
| 2019 |
Padovani L, Horan G, Ajithkumar T. Radiotherapy Advances in Paediatric Medulloblastoma Treatment. Clinical Oncology. 31: 171-181. PMID 30655168 DOI: 10.1016/J.Clon.2019.01.001 |
0.335 |
|
| 2019 |
Feuvret L, Douzane H, Jenny C, D’Hombres A, Padovani L, Aumont M, Noel G, Jacob J, Riet FG, Canova CH, Dehais C, Fauchon F, Meng Y, Dhermain F. PO-0753 radiotherapy quality assurance-POLCA trialpatients with anaplastic oligodendroglial tumors Radiotherapy and Oncology. 133. DOI: 10.1016/S0167-8140(19)31173-9 |
0.319 |
|
| 2019 |
Carrie C, Kieffer V, Figarella-Branger D, Masliah-Planchon J, Bolle S, Leseur J, Supiot S, Laprie A, Bernier V, Dufour C, Huchet A, Coche-Dequeant B, Truc G, Vigneron C, Alapetite C, ... ... Padovani L, et al. Medulloblastoma Molecular Subgroup and Hyperfractionated Radiation Therapy Alone for Standard Risk Medulloblastoma : Results of the Pool Data of MSFOP 1998 and 2007 Studies International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.600 |
0.658 |
|
| 2018 |
Muracciole X, El-Amine W, Tabouret E, Boucekine M, Barlier A, Petrirena G, Harivony T, Solignac L, Chinot OL, Macagno N, Figarella-Branger D, Padovani L. Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population. Frontiers in Oncology. 8: 426. PMID 30338243 DOI: 10.3389/Fonc.2018.00426 |
0.429 |
|
| 2018 |
Legouté F, Padovani L, Claude L, Bolle S, Attal J, Gonzalez-Moya A, Lizée T, Paumier A, Jadaud É, Pointreau Y, Dufreneix S, Laprie A. [Interest of image-guided radiotherapy for brain tumors and positioning control]. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. PMID 30131268 DOI: 10.1016/J.Canrad.2018.06.006 |
0.324 |
|
| 2018 |
Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner V, Huchet A, Leseur J, et al. Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013. International Journal of Radiation Oncology, Biology, Physics. 102: 166-173. PMID 30102193 DOI: 10.1016/J.Ijrobp.2018.05.036 |
0.339 |
|
| 2018 |
Appay R, Fina F, Macagno N, Padovani L, Colin C, Barets D, Ordioni J, Scavarda D, Giangaspero F, Badiali M, Korshunov A, M Pfister S, T W Jones D, Figarella-Branger D. Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29802359 DOI: 10.1038/S41379-018-0050-6 |
0.694 |
|
| 2018 |
Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, et al. SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29729847 DOI: 10.1016/J.Radonc.2018.04.016 |
0.331 |
|
| 2018 |
Petrirena GJ, Masliah-Planchon J, Sala Q, Pourroy B, Frappaz D, Tabouret E, Graillon T, Gentet JC, Delattre O, Chinot O, Padovani L. Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression. Oncotarget. 9: 10175-10183. PMID 29515801 DOI: 10.18632/Oncotarget.23699 |
0.582 |
|
| 2018 |
Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Padovani L, Jouin A, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Kerr C, Le Prisé E, Bertozzi-Salamon AI, et al. Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29500084 DOI: 10.1016/J.Radonc.2018.02.008 |
0.362 |
|
| 2018 |
Padovani L, Chapon F, André N, Boucekine M, Geoffray A, Bourdeau F, Masliah-Planchon J, Claude L, Huchet A, Laprie A, Supiot S, Coche-Dequéant B, Kerr C, Alapetite C, Leseur J, et al. Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases? International Journal of Radiation Oncology, Biology, Physics. 100: 980-986. PMID 29485078 DOI: 10.1016/J.Ijrobp.2017.12.265 |
0.348 |
|
| 2018 |
Tensaouti F, Ducassou A, Bolle S, Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L, Muracciole X, Supiot S, Huchet A, Leseur J, Kerr C, et al. 19 Is dose escalation in intracranial pediatric ependymoma feasible with advanced radiation techniques Physica Medica. 56: 12. DOI: 10.1016/J.Ejmp.2018.09.032 |
0.307 |
|
| 2017 |
Berland M, Padovani L, Rome A, Pech-Gourg G, Figarella-Branger D, André N. Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report. Frontiers in Pharmacology. 8: 792. PMID 29163174 DOI: 10.3389/Fphar.2017.00792 |
0.551 |
|
| 2017 |
Appay R, Macagno N, Padovani L, Korshunov A, Kool M, André N, Scavarda D, Pietsch T, Figarella-Branger D. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases. The American Journal of Surgical Pathology. PMID 28704208 DOI: 10.1097/Pas.0000000000000866 |
0.536 |
|
| 2017 |
Ciccolini J, Barbolosi D, Meille C, Lombard A, Serdjebi C, Giacometti S, Padovani L, Pasquier E, Andre N. Pharmacokinetics and pharmacodynamics-based mathematical modeling identifies an optimal protocol for metronomic chemotherapy. Cancer Research. PMID 28655786 DOI: 10.1158/0008-5472.Can-16-3130 |
0.344 |
|
| 2016 |
Fina F, Barets D, Colin C, Bouvier C, Padovani L, Nanni-Metellus I, Ouafik L, Scavarda D, Korshunov A, Jones DT, Figarella-Branger D. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors. Oncotarget. PMID 27791984 DOI: 10.18632/Oncotarget.12881 |
0.742 |
|
| 2016 |
Tabouret E, Denicolai E, Delfino C, Graillon T, Boucard C, Nanni I, Padovani L, Figarella-Branger D, Chinot O. Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma. Journal of Neuro-Oncology. 130: 431-437. PMID 27566180 DOI: 10.1007/S11060-016-2251-5 |
0.777 |
|
| 2016 |
Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, ... ... Padovani L, et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathologica. PMID 27040285 DOI: 10.1007/S00401-016-1569-6 |
0.352 |
|
| 2016 |
Heng MA, Padovani L, Dory-Lautrec P, Gentet JC, Verschuur A, Pasquier E, Figarella-Branger D, Scavarda D, André N. Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma? Cancer Medicine. 5: 1542-5. PMID 27037940 DOI: 10.1002/Cam4.699 |
0.52 |
|
| 2016 |
Gandola L, Horan G, Meroni S, Giralt J, Mayles H, Thorp N, Bailey S, Pizer B, Ramos M, Padovani L, Andre N, Malet C, Doz F, Janssens GO, Oldenburger F, et al. Mb-49Intensive Treatment Of High-Risk Medulloblastoma (Hr-Mb): How To Learn From Toxicities In An European Setting Of Radiotherapists And Physicists Of The Siop Brain Tumor Working Group Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now076.47 |
0.301 |
|
| 2015 |
Horwitz M, Dufour C, Leblond P, Bourdeaut F, Faure-Conter C, Bertozzi AI, Delisle MB, Palenzuela G, Jouvet A, Scavarda D, Vinchon M, Padovani L, Gaudart J, Branger DF, Andre N. Embryonal tumors with multilayered rosettes in children: the SFCE experience. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. PMID 26438544 DOI: 10.1007/S00381-015-2920-2 |
0.351 |
|
| 2015 |
Ducassou A, Gambart M, Munzer C, Padovani L, Carrie C, Haas-Kogan D, Bernier-Chastagner V, Demoor C, Claude L, Helfre S, Bolle S, Leseur J, Huchet A, Rubie H, Valteau-Couanet D, et al. Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. 191: 604-12. PMID 25896312 DOI: 10.1007/S00066-015-0837-Z |
0.326 |
|
| 2015 |
Tabouret E, Tchoghandjian A, Denicolai E, Delfino C, Metellus P, Graillon T, Boucard C, Nanni I, Padovani L, Ouafik L, Figarella-Branger D, Chinot O. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway. Oncotarget. 6: 11664-75. PMID 25860928 DOI: 10.18632/Oncotarget.3256 |
0.763 |
|
| 2015 |
Nguyen AT, Colin C, Nanni-Metellus I, Padovani L, Maurage CA, Varlet P, Miquel C, Uro-Coste E, Godfraind C, Lechapt-Zalcman E, Labrousse F, Gauchotte G, Silva K, Jouvet A, Figarella-Branger D, et al. Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours. Neuropathology and Applied Neurobiology. 41: 403-8. PMID 25389051 DOI: 10.1111/Nan.12196 |
0.646 |
|
| 2014 |
Jiguet Jiglaire C, Baeza-Kallee N, Denicolaï E, Barets D, Metellus P, Padovani L, Chinot O, Figarella-Branger D, Fernandez C. Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening. Experimental Cell Research. 321: 99-108. PMID 24355810 DOI: 10.1016/J.Yexcr.2013.12.010 |
0.753 |
|
| 2014 |
De Cock L, Sala Q, Barrie M, Boucard C, Terciolo A, Graillon T, Metellus P, Autran D, Tabouret E, Padovani L, Figarella-Branger D, Dufour H, Chinot OL. Patterns of care and outcome for patients with recurrent glioblastoma (GB). Journal of Clinical Oncology. 32: e13007-e13007. DOI: 10.1200/Jco.2014.32.15_Suppl.E13007 |
0.657 |
|
| 2014 |
Tabouret E, Tchoghandjian A, Denicolai E, Delfino C, Metellus P, Padovani L, Nanni I, Barrie M, Boucard C, Ouafik L, Figarella-Branger D, Chinot OL. Expression profile of angiogenic factors in paired initial and recurrent glioblastoma. Journal of Clinical Oncology. 32: 2060-2060. DOI: 10.1200/Jco.2014.32.15_Suppl.2060 |
0.77 |
|
| 2014 |
Tabouret E, Tchoghandjian A, Denicolai E, Delfino C, Metellus P, Padovani L, Nanni I, Barrie M, Boucard C, Ouafik L, Figarella-Branger D, Chinot O. AI-29 * ANGIOGENIC SWITCH FROM VEGFR2/HIF1 IN NEWLY DIAGNOSED GLIOBLASTOMA (GB) TO CXCR4-SDF1 PATHWAY IN RECURRENT PAIRED TUMOR AFTER RADIOTHERAPY (RT)-TEMOZOLOMIDE (TMZ) Neuro-Oncology. 16: v7-v7. DOI: 10.1093/Neuonc/Nou238.29 |
0.794 |
|
| 2014 |
De Cock L, Sala Q, Barrie M, Boucard C, Metellus P, Tabouret E, Padovani L, Figarella-Branger D, Dufour H, Chinot O. P17.20 * PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA Neuro-Oncology. 16: ii91-ii91. DOI: 10.1093/Neuonc/Nou174.350 |
0.648 |
|
| 2013 |
Mercurio S, Padovani L, Colin C, Carré M, Tchoghandjian A, Scavarda D, Lambert S, Baeza-Kallee N, Fernandez C, Chappé C, André N, Figarella-Branger D. Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma. Acta Neuropathologica Communications. 1: 17. PMID 24252689 DOI: 10.1186/2051-5960-1-17 |
0.74 |
|
| 2013 |
Martin V, Moyal É, Delannes M, Padovani L, Sunyach MP, Feuvret L, Dhermain F, Noël G, Laprie A. [Radiotherapy for brain tumors: which margins should we apply?]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 17: 434-43. PMID 24011792 DOI: 10.1016/J.Canrad.2013.07.136 |
0.336 |
|
| 2013 |
Figarella-Branger D, Chappe C, Padovani L, Mercurio S, Colin C, Forest F, Bouvier C. [Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification]. Bulletin Du Cancer. 100: 715-26. PMID 23831947 DOI: 10.1684/Bdc.2013.1789 |
0.768 |
|
| 2013 |
Chappé C, Padovani L, Scavarda D, Forest F, Nanni-Metellus I, Loundou A, Mercurio S, Fina F, Lena G, Colin C, Figarella-Branger D. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathology (Zurich, Switzerland). 23: 574-83. PMID 23442159 DOI: 10.1111/Bpa.12048 |
0.771 |
|
| 2013 |
Colin C, Padovani L, Chappé C, Mercurio S, Scavarda D, Loundou A, Frassineti F, André N, Bouvier C, Korshunov A, Lena G, Figarella-Branger D. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Neuropathology and Applied Neurobiology. 39: 693-705. PMID 23278243 DOI: 10.1111/Nan.12013 |
0.739 |
|
| 2013 |
Metellus P, Tabouret E, Tallet A, Figarella D, Goncalves A, Barlesi F, Padovani L, Regis J, Fuentes S, Dufour H. Radiochirurgie du lit tumoral après résection chirurgicale d’une métastase cérébrale : un nouveau paradigme pour surseoir à la radiothérapie pancérébrale adjuvante Neurochirurgie. 59: 241. DOI: 10.1016/J.Neuchi.2013.10.052 |
0.577 |
|
| 2012 |
Padovani L, Colin C, Fernandez C, Maues de Paula A, Mercurio S, Scavarda D, Frassineti F, Adélaïde J, Loundou A, Intagliata D, Bouvier C, Lena G, Birnbaum D, Girard N, Figarella-Branger D. Search for distinctive markers in DNT and cortical grade II glioma in children: same clinicopathological and molecular entities? Current Topics in Medicinal Chemistry. 12: 1683-92. PMID 22978341 DOI: 10.2174/156802612803531450 |
0.74 |
|
| 2012 |
Padovani L, Muracciole X, Régis J. γ knife radiosurgery of brain metastasis from breast cancer. Progress in Neurological Surgery. 25: 156-62. PMID 22236677 DOI: 10.1159/000331189 |
0.322 |
|
| 2011 |
Padovani L, Andre N, Gentet JC, Figarella Branger D, Scavarda D, Verschuur A, Chinot O, Cowen D, Muracciole X. Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease? Journal of Pediatric Hematology/Oncology. 33: 600-4. PMID 22042276 DOI: 10.1097/Mph.0B013E3182331Eaf |
0.385 |
|
| 2011 |
André N, Padovani L, Pasquier E. Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy? Future Oncology (London, England). 7: 385-94. PMID 21417902 DOI: 10.2217/Fon.11.11 |
0.355 |
|
| 2010 |
André N, Padovani L, Verschuur A. Metronomic chemotherapy: Back to the future! Drug News & Perspectives. 23: 143-51. PMID 20369080 DOI: 10.1358/Dnp.2010.23.2.1475913 |
0.311 |
|
| 2009 |
Padovani L, André N, Carrie C, Muracciole X. [Childhood and adult medulloblastoma: what difference?]. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. 13: 530-5. PMID 19713143 DOI: 10.1016/J.Canrad.2009.06.024 |
0.39 |
|
| 2009 |
Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Baron MH, Clavere P, Chapet S, Maingon P, et al. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: Long-term results of MSFOP 98 Journal of Clinical Oncology. 27: 1879-1883. PMID 19273707 DOI: 10.1200/Jco.2008.18.6437 |
0.471 |
|
| 2009 |
Padovani L, Leseur J, André N, Figarella-Branger D, Lena G, Frappaz D, Gentet J, Carrie C, Cowen D, Muracciole X. Pediatric Medulloblastoma: Educational Long-term Outcome and Clinical Factors International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1177 |
0.429 |
|
| 2008 |
Padovani L, Dahan L, Blesius A, Mercier C, Duluc M, Giacometti S, Duffaud F, Favre R, Seitz J, Ciccolini J. Anticipating gemcitabine-related severe/lethal toxicities: A feasibility study Journal of Clinical Oncology. 26: 14652-14652. DOI: 10.1200/Jco.2008.26.15_Suppl.14652 |
0.33 |
|
| 2007 |
Padovani L, Sunyach MP, Perol D, Mercier C, Alapetite C, Haie-Meder C, Hoffstetter S, Muracciole X, Kerr C, Wagner JP, Lagrange JL, Maire JP, Cowen D, Frappaz D, Carrie C. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. International Journal of Radiation Oncology, Biology, Physics. 68: 433-40. PMID 17498567 DOI: 10.1016/J.Ijrobp.2006.12.030 |
0.359 |
|
| 2007 |
Seitz JF, Dahan L, Ressiot E, Liprandi A, Giorgi R, D’journo XB, Padovani L, Alibert S, Ries P, Thomas PA. Ki67 labelling index and performance status are predictive factors of response to concomitant radiochemotherapy (RCT) in esophageal cancer Journal of Clinical Oncology. 25: 15119-15119. DOI: 10.1200/Jco.2007.25.18_Suppl.15119 |
0.315 |
|
| 2005 |
Bozec A, Formento P, Ciccolini J, Fanciullino R, Padovani L, Murraciole X, Fischel JL, Milano G. Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation. Molecular Cancer Therapeutics. 4: 1962-71. PMID 16373711 DOI: 10.1158/1535-7163.Mct-05-0108 |
0.318 |
|
| 2003 |
Padovani L, Pommier P, Clippe S S, Martel-Lafay I, Malet C, Poupart M, Zrounba P, Ceruse P, Desmes S, Carrie C, Montbarbon X, Ginestet C. Three-dimensional conformal radiotherapy for paranasal sinus carcinoma: clinical results for 25 patients. International Journal of Radiation Oncology, Biology, Physics. 56: 169-76. PMID 12694835 DOI: 10.1016/S0360-3016(03)00078-6 |
0.309 |
|
| Show low-probability matches. |